{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:44Z","timestamp":1792069904951,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06102-3","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:27:14Z","timestamp":1739186834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin"],"prefix":"10.1007","volume":"151","author":[{"given":"John S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack C.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusul","family":"Al-Marayaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farres","family":"Obeidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"VanderWeele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Hermida","family":"de Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"6102_CR1","doi-asserted-by":"publisher","first-page":"261589","DOI":"10.1155\/2008\/261589","volume":"2008","author":"D Aguilera","year":"2008","unstructured":"Aguilera D, Hayes-Jordan A, Anderson P, Woo S, Pearson M, Green H (2008) Outpatient and home chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor. Sarcoma 2008:261589. https:\/\/doi.org\/10.1155\/2008\/261589","journal-title":"Sarcoma"},{"issue":"3","key":"6102_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/01.pas.0000213375.02171.43","volume":"31","author":"R Alaggio","year":"2007","unstructured":"Alaggio R, Rosolen A, Sartori F et al (2007) Spindle cell Tumor with EWS-WT1 transcript and a favorable clinical course: a variant of DSCT, a variant of Leiomyosarcoma, or a New Entity? Report of 2 Pediatric cases. Am J Surg Pathol 31(3):454. https:\/\/doi.org\/10.1097\/01.pas.0000213375.02171.43","journal-title":"Am J Surg Pathol"},{"key":"6102_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fonc.2020.00518","volume":"10","author":"TS Bexelius","year":"2020","unstructured":"Bexelius TS, Wasti A, Chisholm JC (2020) Mini-review on targeted treatment of Desmoplastic Small Round Cell Tumor. Front Oncol 10:518. https:\/\/doi.org\/10.3389\/fonc.2020.00518","journal-title":"Front Oncol"},{"issue":"10","key":"6102_CR4","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","volume":"76","author":"PM Challita-Eid","year":"2016","unstructured":"Challita-Eid PM, Satpayev D, Yang P et al (2016) Enfortumab Vedotin antibody-drug Conjugate Targeting Nectin-4 is a highly potent Therapeutic Agent in multiple preclinical Cancer models. Cancer Res 76(10):3003\u20133013. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1313","journal-title":"Cancer Res"},{"issue":"1","key":"6102_CR5","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/j.ijrobp.2012.09.005","volume":"85","author":"NB Desai","year":"2013","unstructured":"Desai NB, Stein NF, LaQuaglia MP et al (2013) Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience. Int J Radiat Oncol Biol Phys 85(1):e67\u201372. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.09.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"6102_CR6","doi-asserted-by":"publisher","first-page":"10694","DOI":"10.1002\/cam4.5829","volume":"12","author":"C Giani","year":"2023","unstructured":"Giani C, Radaelli S, Miceli R et al (2023) Long-term survivors with desmoplastic small round cell tumor (DSRCT): results from a retrospective single-institution case series analysis. Cancer Med 12(9):10694\u201310703. https:\/\/doi.org\/10.1002\/cam4.5829","journal-title":"Cancer Med"},{"issue":"2","key":"6102_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41585-020-00394-5","volume":"18","author":"EI Heath","year":"2021","unstructured":"Heath EI, Rosenberg JE (2021) The biology and rationale of targeting nectin-4 in urothelial carcinoma. Nat Rev Urol 18(2):93\u2013103. https:\/\/doi.org\/10.1038\/s41585-020-00394-5","journal-title":"Nat Rev Urol"},{"issue":"5","key":"6102_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/14737140.2023.2200171","volume":"23","author":"S Hovsepyan","year":"2023","unstructured":"Hovsepyan S, Giani C, Pasquali S et al (2023) Desmoplastic small round cell tumor: from state of the art to future clinical prospects. Expert Rev Anticancer Ther 23(5):471\u2013484. https:\/\/doi.org\/10.1080\/14737140.2023.2200171","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"6102_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1158\/1078-0432.CCR-22-1764","volume":"29","author":"N Kl\u00fcmper","year":"2023","unstructured":"Kl\u00fcmper N, Ralser DJ, Ellinger J et al (2023) Membranous NECTIN-4 expression frequently decreases during metastatic spread of Urothelial Carcinoma and is Associated with Enfortumab Vedotin Resistance. Clin Cancer Res 29(8):1496\u20131505. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1764","journal-title":"Clin Cancer Res"},{"issue":"20","key":"6102_CR10","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1200\/JCO.23.01983","volume":"42","author":"N Kl\u00fcmper","year":"2024","unstructured":"Kl\u00fcmper N, Tran NK, Zsch\u00e4bitz S et al (2024) NECTIN4 amplification is frequent in solid tumors and predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. J Clin Oncol 42(20):2446\u20132455. https:\/\/doi.org\/10.1200\/JCO.23.01983","journal-title":"J Clin Oncol"},{"issue":"5","key":"6102_CR11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1200\/JCO.1996.14.5.1526","volume":"14","author":"BH Kushner","year":"1996","unstructured":"Kushner BH, LaQuaglia MP, Wollner N et al (1996) Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol off J Am Soc Clin Oncol 14(5):1526\u20131531. https:\/\/doi.org\/10.1200\/JCO.1996.14.5.1526","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"8","key":"6102_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.12998\/wjcc.v2.i8.367","volume":"2","author":"L Liang","year":"2014","unstructured":"Liang L, Tatevian N, Bhattacharjee M, Tsao K, Hicks J (2014) Desmoplastic small round cell tumor with atypical immunohistochemical profile and rhabdoid-like differentiation. World J Clin Cases WJCC 2(8):367\u2013372. https:\/\/doi.org\/10.12998\/wjcc.v2.i8.367","journal-title":"World J Clin Cases WJCC"},{"key":"6102_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030498","author":"CA Mello","year":"2021","unstructured":"Mello CA, Campos FAB, Santos TG et al (2021) Desmoplastic small round cell tumor: a review of Main Molecular abnormalities and emerging therapy. Cancers 13(3). https:\/\/doi.org\/10.3390\/cancers13030498","journal-title":"Cancers"},{"issue":"12","key":"6102_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","volume":"384","author":"T Powles","year":"2021","unstructured":"Powles T, Rosenberg JE, Sonpavde GP et al (2021) Enfortumab Vedotin in previously treated Advanced Urothelial Carcinoma. N Engl J Med 384(12):1125\u20131135. https:\/\/doi.org\/10.1056\/NEJMoa2035807","journal-title":"N Engl J Med"},{"issue":"10","key":"6102_CR15","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41379-021-00843-5","volume":"34","author":"JK Schoolmeester","year":"2021","unstructured":"Schoolmeester JK, Folpe AL, Nair AA et al (2021) EWSR1-WT1 gene fusions in neoplasms other than desmoplastic small round cell tumor: a report of three unusual tumors involving the female genital tract and review of the literature. Mod Pathol 34(10):1912\u20131920. https:\/\/doi.org\/10.1038\/s41379-021-00843-5","journal-title":"Mod Pathol"},{"issue":"1","key":"6102_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.humpath.2014.09.015","volume":"46","author":"N Ud Din","year":"2015","unstructured":"Ud Din N, Pekmezci M, Javed G et al (2015) Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical course. Hum Pathol 46(1):153\u2013158","journal-title":"Hum Pathol"},{"issue":"5","key":"6102_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ccr3.558","volume":"4","author":"S Wakahashi","year":"2016","unstructured":"Wakahashi S, Sudo T, Ichida K et al (2016) Diagnosis of desmoplastic small-round\u2010cell tumor by cytogenetic analysis: a case report. Clin Case Rep 4(5):520\u2013523. https:\/\/doi.org\/10.1002\/ccr3.558","journal-title":"Clin Case Rep"},{"issue":"4","key":"6102_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/08998280.2022.2049581","volume":"35","author":"SHB Waqar","year":"2022","unstructured":"Waqar SHB, Ali H Changing incidence and survival of desmoplastic small round cell tumor in the USA. Proc Bayl Univ Med Cent. 35(4):415\u2013419. https:\/\/doi.org\/10.1080\/08998280.2022.2049581","journal-title":"Proc Bayl Univ Med Cent"},{"key":"6102_CR19","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.epsc.2023.102691","volume":"96","author":"K Yamauchi","year":"2023","unstructured":"Yamauchi K, Owari M, Kimura K, Ishii T, Wakasa T, Yonekura T (2023) Desmoplastic small round cell tumor: a case report and literature review. J Pediatr Surg Case Rep 96:102691. https:\/\/doi.org\/10.1016\/j.epsc.2023.102691","journal-title":"J Pediatr Surg Case Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06102-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:27:14Z","timestamp":1741814834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06102-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["6102"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06102-3","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"73"}}